Sara Viera

698 total citations
10 papers, 318 citations indexed

About

Sara Viera is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Sara Viera has authored 10 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 5 papers in Computational Theory and Mathematics and 3 papers in Infectious Diseases. Recurrent topics in Sara Viera's work include Malaria Research and Control (10 papers), Mosquito-borne diseases and control (7 papers) and Computational Drug Discovery Methods (5 papers). Sara Viera is often cited by papers focused on Malaria Research and Control (10 papers), Mosquito-borne diseases and control (7 papers) and Computational Drug Discovery Methods (5 papers). Sara Viera collaborates with scholars based in Spain, United States and Switzerland. Sara Viera's co-authors include Íñigo Angulo‐Barturen, Marı́a Belén Jiménez-Dı́az, Javier Ibáñez, Domingo Gargallo‐Viola, Leonard D. Shultz, Vanessa Gómez‐Vallejo, Antonio Martı́nez, Francisco‐Javier Gamo, Laura M. Sanz and Yolanda Maneiro Vázquez and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Sara Viera

10 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Viera Spain 9 249 96 60 51 49 10 318
Sonia Lozano Spain 8 220 0.9× 78 0.8× 62 1.0× 48 0.9× 50 1.0× 14 384
Nurhidanatasha Abu-Bakar Malaysia 6 266 1.1× 104 1.1× 72 1.2× 29 0.6× 34 0.7× 12 352
Melanie Wree United States 5 198 0.8× 67 0.7× 49 0.8× 43 0.8× 27 0.6× 5 233
Victoria Corey United States 9 221 0.9× 72 0.8× 82 1.4× 22 0.4× 41 0.8× 11 297
Grennady Wirjanata United Kingdom 11 256 1.0× 88 0.9× 161 2.7× 28 0.5× 62 1.3× 18 443
Pak Prayoga Australia 8 219 0.9× 32 0.3× 52 0.9× 42 0.8× 53 1.1× 9 302
Dipak Kumar Raj United States 9 298 1.2× 53 0.6× 80 1.3× 68 1.3× 68 1.4× 19 369
Mariëtte van der Watt South Africa 11 162 0.7× 63 0.7× 80 1.3× 18 0.4× 42 0.9× 20 276
Michelle Gazdik Australia 7 216 0.9× 71 0.7× 92 1.5× 49 1.0× 25 0.5× 7 324
Tuo Yang Australia 7 364 1.5× 138 1.4× 120 2.0× 27 0.5× 70 1.4× 8 467

Countries citing papers authored by Sara Viera

Since Specialization
Citations

This map shows the geographic impact of Sara Viera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Viera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Viera more than expected).

Fields of papers citing papers by Sara Viera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Viera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Viera. The network helps show where Sara Viera may publish in the future.

Co-authorship network of co-authors of Sara Viera

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Viera. A scholar is included among the top collaborators of Sara Viera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Viera. Sara Viera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Donini, Cristina, Brice Campo, Grant Langdon, et al.. (2021). Chemoprotective Antimalarial Activity of P218 against Plasmodium falciparum: A Randomized, Placebo-Controlled Volunteer Infection Study. American Journal of Tropical Medicine and Hygiene. 104(4). 1348–1358. 21 indexed citations
2.
Mandt, Rebecca, María José Lafuente-Monasterio, Tomoyo Sakata‐Kato, et al.. (2019). In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection model. Science Translational Medicine. 11(521). 22 indexed citations
3.
Miguel-Blanco, Celia, Irene T. Molina‐Martínez, Ana I. Bardera, et al.. (2017). Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen. Nature Communications. 8(1). 15160–15160. 35 indexed citations
4.
Viera, Sara, et al.. (2016). New molecular settings to support in vivo anti-malarial assays. Malaria Journal. 15(1). 147–147. 1 indexed citations
5.
Linares, María, Sara Viera, Benigno Crespo, et al.. (2015). Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay. Malaria Journal. 14(1). 441–441. 28 indexed citations
6.
Vahermo, Mikko, Antti Siiskonen, Lluís Ballell, et al.. (2015). A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides. Journal of Medicinal Chemistry. 58(11). 4573–4580. 12 indexed citations
7.
Jiménez-Dı́az, Marı́a Belén, Sara Viera, Elena Fernández‐Álvaro, & Íñigo Angulo‐Barturen. (2013). Animal models of efficacy to accelerate drug discovery in malaria. Parasitology. 141(1). 93–103. 17 indexed citations
8.
Jiménez-Dı́az, Marı́a Belén, Sara Viera, Javier Ibáñez, et al.. (2013). A New In Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery. PLoS ONE. 8(6). e66967–e66967. 21 indexed citations
9.
Jiménez-Dı́az, Marı́a Belén, Sara Viera, Vanessa Gómez‐Vallejo, et al.. (2009). Improved Murine Model of Malaria UsingPlasmodium falciparumCompetent Strains and Non-Myelodepleted NOD-scid IL2RγnullMice Engrafted with Human Erythrocytes. Antimicrobial Agents and Chemotherapy. 53(10). 4533–4536. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026